WO2003019137A3 - Methods for screening antibody-producing cells on heterogenous antigen substrates - Google Patents

Methods for screening antibody-producing cells on heterogenous antigen substrates Download PDF

Info

Publication number
WO2003019137A3
WO2003019137A3 PCT/US2002/026529 US0226529W WO03019137A3 WO 2003019137 A3 WO2003019137 A3 WO 2003019137A3 US 0226529 W US0226529 W US 0226529W WO 03019137 A3 WO03019137 A3 WO 03019137A3
Authority
WO
WIPO (PCT)
Prior art keywords
antigens
methods
producing cells
binding
screening antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/026529
Other languages
French (fr)
Other versions
WO2003019137A2 (en
Inventor
Steven Kessler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU2002332595A priority Critical patent/AU2002332595A1/en
Publication of WO2003019137A2 publication Critical patent/WO2003019137A2/en
Publication of WO2003019137A3 publication Critical patent/WO2003019137A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Methods and compounds are disclosed that relate to screening and selection of monoclonal antibodies specific for antigens in heterogeneous antigen mixtures. Antibody-secreting cells such as hybridomas are modified to make them capable of directly binding antigens by capturing their secreted antibody products onto their surface membranes in appropriate binding density and orientation. Selectivity of binding to novel or desired antigens is achieved by first reacting the antigen mixtures affixed to a solid substrate with a polyclonal antibody library that prevents access to the majority of antigens or epitopes other than those that are novel or desired.
PCT/US2002/026529 2001-08-22 2002-08-21 Methods for screening antibody-producing cells on heterogenous antigen substrates Ceased WO2003019137A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002332595A AU2002332595A1 (en) 2001-08-22 2002-08-21 Methods for screening antibody-producing cells on heterogenous antigen substrates

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31407001P 2001-08-22 2001-08-22
US60/314,070 2001-08-22

Publications (2)

Publication Number Publication Date
WO2003019137A2 WO2003019137A2 (en) 2003-03-06
WO2003019137A3 true WO2003019137A3 (en) 2003-11-27

Family

ID=23218424

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/026529 Ceased WO2003019137A2 (en) 2001-08-22 2002-08-21 Methods for screening antibody-producing cells on heterogenous antigen substrates

Country Status (2)

Country Link
AU (1) AU2002332595A1 (en)
WO (1) WO2003019137A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006017174A2 (en) * 2004-07-10 2006-02-16 Alexion Pharmaceuticals, Inc. Antibodies against cancer produced using masked cancer cells as immunogen
EP2708890B1 (en) 2012-09-14 2015-11-18 Molecular Devices (New Milton) Ltd Method of selecting a monoclonal cell colony

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6250050B1 (en) * 2000-03-13 2001-06-26 North American Container Corp. Wing-end wood-cleated corrugated paperboard container and method
US6335163B1 (en) * 1994-01-31 2002-01-01 The Trustees Of Boston University Polyclonal antibody libraries

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335163B1 (en) * 1994-01-31 2002-01-01 The Trustees Of Boston University Polyclonal antibody libraries
US6250050B1 (en) * 2000-03-13 2001-06-26 North American Container Corp. Wing-end wood-cleated corrugated paperboard container and method

Also Published As

Publication number Publication date
AU2002332595A1 (en) 2003-03-10
WO2003019137A2 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
DK0765478T3 (en) Positive and positive / negative cell selection mediated by peptide release
CA2348379A1 (en) Immunoassay for measuring human c-peptide and kit therefor
HK1048477A1 (en) Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
EP0134552A3 (en) Monoclonal antibody with a high affinity for digoxin
WO2002016401A3 (en) Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof
DE69526665D1 (en) ANTI-BINDING PEPTIDES (ABTIDES) FROM PEPTIDE LIBRARIES
RU96107203A (en) MONOCLONAL ANTIBODIES WITH THE ABILITY TO CAUSE APOPTOSIS
EP2186884A3 (en) HCV-anti-core monoclonal antibody
IE810795L (en) Monoclonal antibodies against hepatitis b virus
CA2057058A1 (en) Monoclonal antibodies to c-reactive protein
CA2221682A1 (en) Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent
ATE375802T1 (en) CCR5 ANTIBODIES PA14
Tsutsumi et al. Anti-idiotype monoclonal antibodies against anti-microcystin antibody and their use in enzyme immunoassay
WO2003019137A3 (en) Methods for screening antibody-producing cells on heterogenous antigen substrates
EP1072888A3 (en) Immunoassay method and reagent for HIV-1p24 antigen
CA2332131A1 (en) Serine protease-specific monoclonal antibody and utilization thereof
EP0268987A3 (en) Assays for antibody to hepatitis b core antigen
CA2080548A1 (en) Monoclonal antibodies to hepatitis c virus
EP0104014A3 (en) Cell surface antigens of human astrocytoma
WO2004021871A3 (en) Hcv assay
Becker et al. An alternative ELISA for T4 determination based on idiotype anti-idiotype interaction and a latex method for anti-idiotype monoclonal antibody selection
WO2005026379A3 (en) The mapping and reconstitution of a conformational discontinuous binding surface
DE69733626D1 (en) Monoclonal antibodies against detergents and their degradation products, and their use in immunoassays
EP1094080A3 (en) Anti-dnase-gamma antibody, and production and use thereof
JPS57208458A (en) Labeled antibody for immunochemical measurement

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG UZ VN YU ZA ZM

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP